Selected prostate cancer risk factors by use of cholesterol-lowering drugs, Cancer Prevention Study II Nutrition Cohort
| . | Never use (n = 41,872), % . | Former use (n = 2,057), % . | Current use, <5 y (n = 6,653), % . | Current use, ≥5 y (n = 4,872), % . | ||||
|---|---|---|---|---|---|---|---|---|
| Age (y) | ||||||||
| 50-59 | 4.3 | 3.1 | 3.4 | 2.4 | ||||
| 60-69 | 51.6 | 44.6 | 56.3 | 51.4 | ||||
| 70-79 | 40.4 | 48.9 | 38.6 | 43.6 | ||||
| ≥80 | 3.7 | 3.5 | 1.7 | 2.5 | ||||
| Race | ||||||||
| White | 97.8 | 96.8 | 98.1 | 97.9 | ||||
| Black | 0.9 | 1.7 | 0.6 | 0.8 | ||||
| Other or unknown | 1.2 | 1.5 | 1.4 | 1.3 | ||||
| Education | ||||||||
| <High school | 7.2 | 8.6 | 6.8 | 6.1 | ||||
| High school graduate | 18.2 | 18.7 | 17.9 | 17.7 | ||||
| Some college | 25.1 | 27.5 | 26.2 | 25.2 | ||||
| College graduate | 22.3 | 21.0 | 22.8 | 24.4 | ||||
| Graduate school | 26.6 | 23.7 | 25.7 | 25.9 | ||||
| Unknown | 0.6 | 0.4 | 0.6 | 0.7 | ||||
| BMI | ||||||||
| <25 | 34.5 | 33.9 | 30.6 | 30.4 | ||||
| 25-<30 | 43.4 | 44.7 | 46.5 | 48.2 | ||||
| 30-<35 | 11.6 | 11.3 | 12.3 | 12.0 | ||||
| ≥35 | 2.5 | 2.1 | 2.4 | 2.5 | ||||
| Unknown | 7.9 | 8.0 | 8.2 | 6.9 | ||||
| Family history of prostate cancer | 17.0 | 14.5 | 16.0 | 15.2 | ||||
| NSAID use (pills/mo) | ||||||||
| None | 34.3 | 25.3 | 17.8 | 17.8 | ||||
| 1-14 | 23.8 | 22.9 | 22.5 | 22.6 | ||||
| 15-29 | 8.5 | 8.6 | 6.7 | 7.8 | ||||
| 30-59 | 14.6 | 18.3 | 24.6 | 24.8 | ||||
| ≥60 | 7.5 | 8.1 | 8.0 | 7.9 | ||||
| User, unknown quantity | 11.2 | 16.8 | 20.4 | 19.1 | ||||
| History of PSA testing | ||||||||
| Never | 17.4 | 13.0 | 11.9 | 10.1 | ||||
| Yes, test in last 2 y | 63.8 | 63.9 | 71.1 | 73.7 | ||||
| Yes, test >2 y ago | 10.5 | 12.0 | 8.9 | 8.9 | ||||
| Unknown | 8.3 | 11.1 | 8.0 | 7.3 | ||||
| Elevated cholesterol* | 26.4 | 85.0 | 89.3 | 95.5 | ||||
| Heart attack history | 12.5 | 34.8 | 49.1 | 49.5 | ||||
| Diabetes history | 9.3 | 13.5 | 13.4 | 13.4 | ||||
| . | Never use (n = 41,872), % . | Former use (n = 2,057), % . | Current use, <5 y (n = 6,653), % . | Current use, ≥5 y (n = 4,872), % . | ||||
|---|---|---|---|---|---|---|---|---|
| Age (y) | ||||||||
| 50-59 | 4.3 | 3.1 | 3.4 | 2.4 | ||||
| 60-69 | 51.6 | 44.6 | 56.3 | 51.4 | ||||
| 70-79 | 40.4 | 48.9 | 38.6 | 43.6 | ||||
| ≥80 | 3.7 | 3.5 | 1.7 | 2.5 | ||||
| Race | ||||||||
| White | 97.8 | 96.8 | 98.1 | 97.9 | ||||
| Black | 0.9 | 1.7 | 0.6 | 0.8 | ||||
| Other or unknown | 1.2 | 1.5 | 1.4 | 1.3 | ||||
| Education | ||||||||
| <High school | 7.2 | 8.6 | 6.8 | 6.1 | ||||
| High school graduate | 18.2 | 18.7 | 17.9 | 17.7 | ||||
| Some college | 25.1 | 27.5 | 26.2 | 25.2 | ||||
| College graduate | 22.3 | 21.0 | 22.8 | 24.4 | ||||
| Graduate school | 26.6 | 23.7 | 25.7 | 25.9 | ||||
| Unknown | 0.6 | 0.4 | 0.6 | 0.7 | ||||
| BMI | ||||||||
| <25 | 34.5 | 33.9 | 30.6 | 30.4 | ||||
| 25-<30 | 43.4 | 44.7 | 46.5 | 48.2 | ||||
| 30-<35 | 11.6 | 11.3 | 12.3 | 12.0 | ||||
| ≥35 | 2.5 | 2.1 | 2.4 | 2.5 | ||||
| Unknown | 7.9 | 8.0 | 8.2 | 6.9 | ||||
| Family history of prostate cancer | 17.0 | 14.5 | 16.0 | 15.2 | ||||
| NSAID use (pills/mo) | ||||||||
| None | 34.3 | 25.3 | 17.8 | 17.8 | ||||
| 1-14 | 23.8 | 22.9 | 22.5 | 22.6 | ||||
| 15-29 | 8.5 | 8.6 | 6.7 | 7.8 | ||||
| 30-59 | 14.6 | 18.3 | 24.6 | 24.8 | ||||
| ≥60 | 7.5 | 8.1 | 8.0 | 7.9 | ||||
| User, unknown quantity | 11.2 | 16.8 | 20.4 | 19.1 | ||||
| History of PSA testing | ||||||||
| Never | 17.4 | 13.0 | 11.9 | 10.1 | ||||
| Yes, test in last 2 y | 63.8 | 63.9 | 71.1 | 73.7 | ||||
| Yes, test >2 y ago | 10.5 | 12.0 | 8.9 | 8.9 | ||||
| Unknown | 8.3 | 11.1 | 8.0 | 7.3 | ||||
| Elevated cholesterol* | 26.4 | 85.0 | 89.3 | 95.5 | ||||
| Heart attack history | 12.5 | 34.8 | 49.1 | 49.5 | ||||
| Diabetes history | 9.3 | 13.5 | 13.4 | 13.4 | ||||
NOTE: Percentages were adjusted to the age distribution of the entire study population.
Ever had elevated cholesterol, as self-reported by participants.